Analysed LYELL IMMUNOPHARMA INC (LYEL:NASDAQ) News Sources
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
01-06-2026
yahoo.com
Lyell Immunopharma (LYEL) Loses 39.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
04-06-2026
yahoo.com
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
04-06-2026
yahoo.com
Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion
08-06-2026
yahoo.com
Is Lyell Immunopharma (NASDAQ:LYEL) In A Good Position To Deliver On Growth Plans?
09-06-2026
yahoo.com
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress
12-06-2026
yahoo.com
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
25-06-2026
yahoo.com
Wall Street Analysts Think Lyell Immunopharma (LYEL) Could Surge 176.02%: Read This Before Placing a Bet
02-07-2026
yahoo.com
What is the current price of LYELL IMMUNOPHARMA INC (LYEL:NASDAQ)?
The current price of LYELL IMMUNOPHARMA INC (LYEL:NASDAQ) is $12.94.
LYELL IMMUNOPHARMA INC (LYEL:NASDAQ) absolute price change since previous trading day?
The absolute price change of LYELL IMMUNOPHARMA INC (LYEL:NASDAQ) since the previous trading day is $-0.78.
LYELL IMMUNOPHARMA INC (LYEL:NASDAQ) percentage price change since previous trading day?
The percentage price change of LYELL IMMUNOPHARMA INC (LYEL:NASDAQ) since the previous trading day is -5.6851%.
What is the most recent average sentiment score for LYELL IMMUNOPHARMA INC (LYEL:NASDAQ)?
The most recent average sentiment score for LYELL IMMUNOPHARMA INC (LYEL:NASDAQ) is 52 out of 100.
What is the most recent average sentiment for LYELL IMMUNOPHARMA INC (LYEL:NASDAQ)?
The most recent sentiment for LYELL IMMUNOPHARMA INC (LYEL:NASDAQ) is .
SEC-8K** Filing Available For LYELL IMMUNOPHARMA INC (LYEL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.